Diagnostic Values of Urinary Biomarkers in Early Diagnosis of Diabetic Nephropathy

被引:1
作者
Hu Shufang [1 ]
Cheng Kui [1 ]
Yang Li [1 ]
Zhang Yu [2 ]
机构
[1] Hankou Hosp Wuhan City, Dept Endocrinol, Wuhan 430012, Hubei, Peoples R China
[2] Huazhong Univ & Technol, Tongji Med Coll, Pu Ai Hosp, Dept Endocrinol, Wuhan 430012, Hubei, Peoples R China
关键词
Diabetic nephropathy; urinary biomarkers; early diagnosis; kidney loss; clinical monitoring; microalbuminuria; urinary transferring; macroalbuminuria; GELATINASE-ASSOCIATED LIPOCALIN; RETINOL-BINDING-PROTEIN; NGAL LEVELS; EXCRETION; FEATURES; ALPHA; RBP;
D O I
10.3923/ijp.2019.851.856
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background and Objective: The diagnosis of type 2 diabetic nephropathy (T2DN) patients is important to prevent the long-term damaging effects of kidney loss in patients with diabetes. The aim of this study was to explore diagnostic values of Urinary RBP levels, NGAL, ZAG and urinary transferrin in early diagnosis of diabetic nephropathy. Materials and Methods: The total sample size was comprised of 400 patients, 300 subjects were of type 2 diabetes mellitus and 100 subjects were considered under the control subjects without any systemic illness. According the ratio of urine and albumin urine creatinine, subjects were further divided into 3 sub-categories: normoalbuminuria, microalbuminuria and macroalbuminuria group. Human ELISA kit had been used for the evaluation of Urine urinary RBP, NGAL, Adipokine zinc-alpha-2-glycoprotein and urinary transferring. Results: The level of u-NCR, u-RCR, u-ZCR, u-TCR levels in the macroalbuminuria and microalbuminuria were markedly and significantly high when compared with normoalbuminuria and control subjects. So, when the stages of diabetic nephropathy are going critical, the levels of all the biomarkers also increasing in their value. urinary transferrin and RBP have excellent diagnostic accuracy with AUC = 1-0.9. Conclusion: This study concluded that the evaluation of urinary RBP, NGAL, ZAG and urinary transferrin could be use as novel and accurate biomarker for the early diagnosis, clinical monitoring and progression of diabetic nephropathy patients.
引用
收藏
页码:851 / 856
页数:6
相关论文
共 22 条
  • [1] Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)
    Adler, AI
    Stevens, RJ
    Manley, SE
    Bilous, RW
    Cull, CA
    Holman, RR
    [J]. KIDNEY INTERNATIONAL, 2003, 63 (01) : 225 - 232
  • [2] Mean platelet volume and platelet counts in type 2 Diabetes: Mellitus on treatment and non-diabetic mellitus controls in Lagos, Nigeria
    Akinsegun, Akinbami
    Olusola, Dada Akinola
    Sarah, John-Olabode
    Olajumoke, Oshinaike
    Adewumi, Adediran
    Majeed, Odesanya
    Anthonia, Ogbera
    Ebele, Uche
    Olaitan, Okunoye
    Olanrewaju, Arogundade
    Kingsley, Aile
    [J]. PAN AFRICAN MEDICAL JOURNAL, 2014, 18
  • [3] Assessment of the diagnostic value of different biomarkers in relation to various stages of diabetic nephropathy in type 2 diabetic patients
    Al-Rubeaan, Khalid
    Siddiqui, Khalid
    Al-Ghonaim, Mohammed A.
    Youssef, Amira M.
    Al-Sharqawi, Ahmed H.
    AlNaqeb, Dhekra
    [J]. SCIENTIFIC REPORTS, 2017, 7
  • [4] Neutrophil Gelatinase-Associated Lipocalin as an Early Biomarker of Nephropathy in Diabetic Patients
    Bolignano, Davide
    Lacquaniti, Antonio
    Coppolino, Giuseppe
    Donato, Valentina
    Fazio, Maria Rosaria
    Nicocia, Giacomo
    Buemi, Michele
    [J]. KIDNEY & BLOOD PRESSURE RESEARCH, 2009, 32 (02) : 91 - 98
  • [5] CHEUNG CK, 1989, CLIN CHEM, V35, P1672
  • [6] Urinary kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin as indicators of tubular damage in normoalbuminuric patients with type 2 diabetes
    de Carvalho, Jose Antonio M.
    Tatsch, Etiane
    Hausen, Bruna S.
    Bollick, Yanai S.
    Moretto, Maria B.
    Duarte, Thiago
    Duarte, Marta M. M. F.
    Londero, Silvia W. K.
    Premaor, Melissa O.
    Comim, Fabio V.
    Delanghe, Joris R.
    Moresco, Rafael N.
    [J]. CLINICAL BIOCHEMISTRY, 2016, 49 (03) : 232 - 236
  • [7] Fiseha T, 2015, BIOMARK RES, V3, DOI 10.1186/s40364-015-0042-3
  • [8] Galanti LM, 1996, DIABETES METAB, V22, P324
  • [9] Urinary Biomarkers in the Assessment of Early Diabetic Nephropathy
    Gluhovschi, Cristina
    Gluhovschi, Gheorghe
    Petrica, Ligia
    Timar, Romulus
    Velciov, Silvia
    Ionita, Ioana
    Kaycsa, Adriana
    Timar, Bogdan
    [J]. JOURNAL OF DIABETES RESEARCH, 2016, 2016
  • [10] Hydrophobic ligand binding by Zn-α2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins
    Kennedy, MW
    Heikema, AP
    Cooper, A
    Bjorkman, PJ
    Sanchez, LM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (37) : 35008 - 35013